Clinical Trial Update: Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene [NA]

View source ↗

Summary

A clinical trial is evaluating cognitive behavioral therapy to address fear of cancer recurrence in women with BRCA1/2 mutations; the study is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Breast Cancer Susceptibility Gene (BRCA1) Mutation, BRCA2 Mutation | NA | Status: RECRUITING